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ABSTRACT An intricate network of reactions is involved in matching energy supply with demand in the heart. This complexity
arises because energy production both modulates and is modulated by the electrophysiological and contractile activity of the
cardiac myocyte. Here, we present an integrated mathematical model of the cardiac cell that links excitation-contraction
coupling with mitochondrial energy generation. The dynamics of the model are described by a system of 50 ordinary differential
equations. The formulation explicitly incorporates cytoplasmic ATP-consuming processes associated with force generation and
ion transport, as well as the creatine kinase reaction. Changes in the electrical and contractile activity of the myocyte are
coupled to mitochondrial energetics through the ATP, Ca21, and Na1 concentrations in the myoplasmic and mitochondrial
matrix compartments. The pseudo steady-state relationship between force and oxygen consumption at various stimulus
frequencies and external Ca21 concentrations is reproduced in both model simulations and direct experiments in cardiac
trabeculae under normoxic conditions, recapitulating the linearity between cardiac work and respiration in the heart. Importantly,
the model can also reproduce the rapid time-dependent changes in mitochondrial NADH and Ca21 in response to abrupt
changes in workload. The steady-state and dynamic responses of the model were conferred by ADP-dependent stimulation of
mitochondrial oxidative phosphorylation and Ca21-dependent regulation of Krebs cycle dehydrogenases, illustrating how the
model can be used as a tool for investigating mechanisms underlying metabolic control in the heart.
INTRODUCTION
Control mechanisms that modulate mitochondrial ATP pro-
duction to match energy consumption are especially impor-
tant in tissues with a high energetic demand like the heart (1).
The proportionality between cardiac work and the rate of
respiration was recognized almost 100 years ago (2), yet the
mechanisms responsible for matching energy supply with de-
mand remain controversial (3). Themetabolic rate can change
by 10- to 15-fold (4,5), but many investigators have observed
that the levels of energy-rich adenine intermediates can be
remarkably constant, indicating that oxidative phosphoryla-
tion is tightly controlled (for review, see (6,7)).
Several hypotheses have been put forward to explain the
control of oxidative phosphorylation. The classical respiratory
control hypothesis of Chance and co-workers (8), which has
been subsequently conﬁrmed in countless experiments on
isolated mitochondria, implies that the rate of respiration is
limited by the availability of ADP to the mitochondrial ATP
synthase (as long as adequate substrates are available to
maintain proton pumping). This demand-led control would be
well suited to increase ATP production in response to cy-
toplasmic ATP consumption, but changes in bulk cytoplasmic
ADP concentration have not been detected in intact hearts at
high workloads by phosphorous NMR methods. Furthermore,
a large increase in total ADP would have an unfavorable effect
on cell processes that are sensitive to the free energy of ATP
hydrolysis (i.e., the phosphorylation potential).
To explain how mitochondrial ADP delivery is acceler-
ated without a large change in the cytoplasmic levels, models
of intracellular dynamic compartmentation of adenine nu-
cleotides have been proposed. This hypothesis is based on
abundant evidence that different creatine kinase isozymes are
localized near the sites of ATP hydrolysis (e.g., the myo-
ﬁbrils) and the mitochondrial inner membrane, contributing
to intracellular-energetic units (9). This view implies that,
whereas bulk ATP/ADP ratios remain constant, ADP signals
generated by the myosin ATPase are rapidly transferred to
the mitochondria via the creatine kinase shuttle. ATP can be
similarly channeled back to the sites of utilization with alter-
ations in the ATP/ADP ratio occurring only in microdomains
close to the relevant sources and sinks of ATP (10). Evidence
for compartmentalization of the adenine nucleotide pool has
been addressed recently by combining biochemical models
of phosphoryl transfer with estimations of CK ﬂuxes by sat-
uration transfer NMR methods (11).
Any mechanism that increases the rate of NADH oxidation
would require concomitant activation of NADH production.
Balaban and co-workers have proposed several mechanisms
by which simultaneous stimulation of work and metabolism
might be coordinated by cytoplasmic messengers. These
include parallel activation of the respiratory chain and mito-
chondrial dehydrogenases by either Ca21 (12) or Pi (1,13). As
elaborated in these studies, very rapid responses in the NADH
production and oxidation processes would virtually eliminate
transients in metabolite levels during changes in work.
Submitted October 14, 2005, and accepted for publication April 24, 2006.
Address reprint requests to Raimond L. Winslow, The Johns Hopkins
University, School of Medicine, Rm. 201B Clark Hall, 3400 N. Charles St.,
Baltimore MD 21218. Tel.: 410-516-5417; E-mail: rwinslow@jhu.edu.
 2006 by the Biophysical Society
0006-3495/06/08/1564/26 $2.00 doi: 10.1529/biophysj.105.076174
1564 Biophysical Journal Volume 91 August 2006 1564–1589
To gain a better understanding of the complex dynamics
of the response of mitochondrial bioenergetics to alterations
in the contractile and electrical activity of the heart cell, and
to explore the feasibility of proposed control mechanisms,
here we integrate models of the electrophysiological, Ca21
handling, and force-generation subsystems of the cardiac
myocyte (14,15) with a model of mitochondrial oxidative
phosphorylation (16). The model is validated by performing
parallel experiments measuring force and oxygen consump-
tion in cardiac trabeculae and by comparison with earlier
data describing transients in NADH and mitochondrial Ca21
during abrupt perturbations of muscle workload (17).
MATHEMATICAL MODEL DEVELOPMENT
Excitation-contraction coupling/mitochondrial
energetics (ECME) model
Fig. 1 shows the integrated model. The scheme emphasizes the links among
mitochondrial metabolism, electrophysiology, and contraction.
Energy intermediates as links between
mitochondrial energetics and excitation-
contraction coupling
The excitation-contraction (EC) coupling (guinea-pig ventricular myocyte)
and mitochondrial energetic models (14,15) are linked by the concentrations
of ATP, ADP, creatine and creatine phosphate, and mitochondrial and cyto-
plasmic Ca21 and Na1.
As discussed above, the currently accepted view that CK functions as
both a cellular energy buffer and a high-energy phosphate shuttle (11,18,19)
required us to introduce into the model a mechanism to simulate both the
rapid transmission of an ADP signal to the mitochondria from the myo-
ﬁlaments and the buffering of the bulk cytoplasmic ATP/ADP ratio by the
creatine kinase (CK) system. To avoid the computational challenge of incor-
porating a spatial dimension and partial differential equations into the model,
we approximated metabolic compartmentation by adding two pools of CK,
creatine, and adenine nucleotides in the cytoplasm (Fig. 1). One pool is as-
sociated with mitochondrial transport through the adenine nucleotide trans-
locator (ANT) and is linked to the EC coupling processes. The other pool
accounts for energy provision to constitutive cytoplasmic processes, e.g.
transport processes and macromolecule synthesis. In our model, adenine nu-
cleotide levels provide a strong link between mitochondrial energetics and
the electrophysiological and contractile processes (see Discussion).
FIGURE 1 General scheme of the EC coupling/mitochondrial energetics (ECME) model. The electrophysiological module includes the main ion transport
processes involved in EC-coupling, accounting for the transport of Ca21, Na1, and K1 across the sarcolemma, Ca21 transport inside and across the SR
membrane, and Ca21 handling by mitochondria. Five different Ca21 compartments are deﬁned including the mitochondrial matrix, the dyadic subspace, the
junctional and network SR, and the myoplasmic compartments. Extracellular Ca21 is considered an adjustable parameter. The mitochondrial module describes
the production (F1, F0 ATPase) and transport (ANT) of ATP, Ca
21 transport, and Ca21 activation of the TCA cycle dehydrogenases. The CK reaction occurs
near the mitochondria (but does not include potential limitations imposed by the outer membrane) and the CrP diffuses to the cytoplasmic compartment where
there is another pool of CK that catalyzes the regeneration of ATPic to fuel constitutive cytoplasmic ATPases (labeled ‘‘cyto’’). Also the total pool of adenine
(CA) and creatine (CC) metabolites are indicated by dark shading. The main ATP-consuming processes related to EC coupling are the myoﬁbrillar ATPase
(VAM) and SERCA (Jup), and in the sarcolemma, the Na
1, K1 ATPase (INaK), and the Ca
21 ATPase (IpCa).
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Our model also deﬁnes two different pools of ATP in the cytoplasm:
ATPi (EC coupling-linked) and ATPic (associated with constitutive cyto-
plasmic ATPases) (see Eqs. 1–5). In each one of these pools the total con-
centration of adenine nucleotides is constant, and the total concentration of
adenine nucleotide, CA, is the same (8 mM). Thus, the following equations
apply:
½ADP
i
¼ CA  ½ATPi; (1)
½ADPic ¼ CA  ½ATPic: (2)
This approach implies that ADP levels are determined by ATP in each
cytoplasmic pool, linked through the creatine metabolites that are exchanged
with the adenine metabolites by the CK catalyzed reaction:
ATP1Cr%
CK
ADP1CrP:
The rate of CK was modeled using mass action kinetics assuming that it
operates close to thermodynamic equilibrium:
VCK ¼ kFCK ½ATP½Cr 
½ADP½CrP
KEQ
 
: (3)
Creatine phosphate (CrP) is synthesized from ATP by the mitochondrial
CK (VmitoCK ) (Eq. A141) and transported to the cytoplasm for its utilization by
constitutive energy-consuming processes through VCrPtr (Eq. A142). The CK
at the cytoplasmic site, VcytoCK (Eq. A140), catalyzes the phosphorylation of
ADP from CrP to generate ATP (CK reaction as written above in the reverse
direction) that will be used by the constitutive cytosolic ATPases ruled by
VcytoATPase(ﬁxed parameter, Table 12). Thus, the direction of the CK reaction
depends on the enzyme localization, i.e., toward CrP synthesis in the mito-
chondria and toward the synthesis of ATP in the cytoplasm. The creatine
metabolite levels in each pool, like the adenine nucleotide concentrations,
are linked through conservation relationships as follows:
½Cri ¼ Cc  ½CrPi; (4)
½Cric ¼ Cc  ½CrPic: (5)
Equations 4 and 5 indicate that the Cr levels in both cytoplasmic pools are
determined by the level of CrP. The parameter Cc (the total concentration of
creatine metabolites) is the same in both pools, 25 mM (Table 12).
Ionic linkages between mitochondrial
energetics and EC coupling
In addition to the ATP and ADP links between mitochondrial and cyto-
plasmic compartments, the mitochondrial concentration of Ca21 ([Ca21]m)
is related to the myoplasmic Ca21 concentration through the activity of the
Ca21 uniporter and the mitochondrial Na1/Ca21 exchanger (NCE). The
NCE senses the cytoplasmic Na1 level that is exchanged with Ca21m . Thus,
mitochondria act as an additional Ca21 and Na1 sink in our model.
The rate expressions accounting for the dynamics of the ATP-consuming
processes in the cytoplasm have been modiﬁed to account for their depen-
dence onATP andADP concentrations. Among those energy-dependent pro-
cesses are: the sarcoplasmic reticulum Ca21 pump (SERCA); the Na1/K1
ATPase; and the sarcolemmal Ca21 pump. The ATP-dependence of the
kinetics of these pumps is detailed in the following sections.
Cytoplasmic ATP-consuming processes
Sarcoplasmic-endoplasmic reticulum Ca21
ATPase (SERCA)
Rice and collaborators (15) adopted the Shannon et al. (20) formulation of
SERCA kinetics. This equation (Eq. 6) incorporates the forward and reverse
modes of Ca21 transport across the sarcoplasmic reticulum (SR) membrane.
We modiﬁed the original rate expression to account for ATP-dependence of
SERCA, in accordance with experimental data obtained in vitro by
Sakamoto and Tonomura (21) using a fragmented SR preparation. These
studies demonstrated a Michaelis-Menten dependence of enzyme activity
with respect to ATP and mixed-type inhibition of the enzyme by ADP under
conditions of high Mg21 and low Ca21. The experimental data (21) were
also incorporated by Jeneson et al. (22) in their model of energy cycling in
human skeletal muscle. Equation 6 represents the rate of the SERCA,
explicitly describing its ATP and ADP dependence. The factor that in-
corporates [ATP]i and [ADP]i in the denominator has been adopted from
Jeneson et al. (22) with the parameter values determined by Sakamoto and
Tonomura (21),
VSERCA ¼ KSR½Vmaxf fb  Vmaxr rb
11 fb1 rb
3
1
K
ATP
m;up
½ATPi 11
½ADP
i
Ki;up
 
1 11
½ADP
i
K9i;up
 ; (6)
being
fb ¼ ½Ca
21 i
Kfb
 Nfb
;
and
rb ¼ ½Ca
21 NSR
Krb
 Nrb
;
where KATPm represents the afﬁnity of SERCA for ATP, and Ki,up and K9i,up
are the ADP inhibition constants (Table 7). As shown experimentally by
Sakamoto and Tonomura (21), Eq. 6 indicates that ADP inhibits the pump
both by competitive (accomplished in the term containing Ki,up) and non-
competitive (accounted for by K9i,up) mechanisms. We simulated the be-
havior of SERCA as a function of Ca21 concentrations in the myoplasm and
inside the SR network (NSR). The introduction of ATP dependence did not
signiﬁcantly change pump rate as a function of Ca21 in the physiological
range of ATPi levels (not shown).
Actomyosin ATPase (AM ATPase)
The data of Regnier et al. (23), concerning mechanisms involved in the
regulation of force generation by cardiac muscle, indicate little sensitivity of
developed muscle tension to large variations in ATP (from 0.5 to 5 mM).
Additionally, Karatzaferi et al. (24) demonstrated that ADP analogs bind to
myosin heads, thereby potentiating tension. Accordingly, we assume that de-
veloped force is only indirectly sensitive to the ratio of ATP to ADP (see Eqs
A96–A121) through the effect of the latter on the SERCA pump, resulting
in reduced sarcoplasmic reticulum Ca21 load leading to reduced developed
force. On the other hand, the rate of ATP hydrolysis associated with force
generation through actomyosin ATPase (Eq. 7) depends explicitly on both
ATP and ADP, as previously demonstrated (25). We have developed a
Michaelis-Menten kinetic expression to account for ATP activation of the ac-
tomyosin ATPase associated with force generation, together with a com-
petitive ADP inhibition:
VAM ¼ VmaxAM
f01½P01 f12½P11 f23½P2
f011 f121 f23
 
3
1
11
K
ATP
M;AM
½ATP
i
11
½ADPi
Ki;AM
 : (7)
Equation 7 contains a factor accounting for dependence of the AM ATPase
on normalized rate of cross-bridge formation through their rate of formation,
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as denoted by f01 [P0], f12 [P1, and f23 [P2] and the rate constants f01, f12, and
f23 (Eqs. A102–A104).
Na1/K1 ATPase
The original expression for the Na1/K1 ATPase corresponds to that in-
troduced by Luo and Rudy in their phase II ventricular cell model (26). This
model was able to account for experimental observations performed by
Nakao and Gadsby (27) regarding the dependence of the current on mem-
brane potential at different external Na1 concentrations. The Na1/K1 cur-
rent expression has been modiﬁed based on kinetic studies of Sakamoto and
Tonomura (21) to account for the dependence of Na1/K1 ATPase activity
on ATP, as well as the competitive inhibition exerted by ADP,
INaK ¼ INaK;max fNaK 1
11
K
ATP
m;NaK
½ATPi
11
½ADPi
K
ADP
i;NaK
 !" #
3
½K1 o
½K1 o1Km;Ko
11
Km;Nai
½Na1 i
 3=2; (8)
being
fNaK ¼ 1
11 0:1245 e 0:1
VF
RTð Þ1 0:0365s e VFRTð Þ
;
with
s ¼ e
½Na1 o
67:3
 
 1
7
:
Sarcolemmal Ca21 ATPase
Equation 9 gives the modiﬁed rate expression incorporating the ATP-
dependence of pump activity. Sarcolemmal Ca21 ATPase rate (Eq. 9) ex-
hibits two different K0.5 values for ATP (K
ATP
m1 pCa; K
ATP
m2 pCa). ADP exerts
competitive inhibition of the Ca21 pump by affecting the high-afﬁnity com-
ponent of the ATP interaction through the inhibition constant, KADPi pCa. We
adopted the K0.5 values described in Echarte et al. (28), who found two K0.5
values for ATP in their study of the enzyme reaction mechanism involving
the formation of an intermediate phosphorylated enzyme state. The afﬁnity
constants for ATP suggested the presence of two nucleotide regulatory sites
in the sarcolemmal Ca21 ATPase (29):
IpCa ¼ IpCa max 1
11
K
ATP
m1 pCa
½ATPi 11
½ADPi
KADPi pCa
 !1 1
11
K
ATP
m2 pCa
½ATPi
2
66664
3
77775
3
½Ca21 
i
K
pCa
m 1 ½Ca21 i
:
(9)
ATP/ADP dependence of the kinetics of the pumps
Fig. 2 displays the behavior of the different pumps introduced in the pre-
vious sections as a function of [ATP]i. To compare the modeling results to
experimental data obtained in vitro, the simulations employed in vitro Vmax
values. These differed from the Vmax values used in the integrated cell model
because adjustments were required to simulate the reported currents or ﬂuxes
measured in intact cardiac myocytes.
The experimental results describing the behavior of the sarcoplasmic
reticulum Ca21 pump (Fig. 2 A) (from (21)) were simulated using the rate
expression (Eq. 6) depicted in Fig. 2 B for the range of ADP concentrations
employed by Sakamoto and Tonomura (21). Only the forward and reverse
Vmax values had to be adjusted in the model (see Table 7) to reproduce the
SERCA pump ﬂuxes obtained experimentally (20).
The dependence of the AMATPase rate on ATP,measured byKaratzaferi
et al. (24) (Fig. 2 C), could be reproduced using the rate expression of Eq. 7
(Fig. 2 D). As a result of the high afﬁnity of the ATPase for the nucleotide,
the rate of ATP consumption by myoﬁbrils will be saturated with ATP in the
physiological concentration range (not shown).
Fig. 2 E shows the current carried by the Na1/K1 ATPase, measured ex-
perimentally by Sakamoto and Tonomura (21), and simulated using the rate
expression shown in Eq. 8 (Fig. 2 F). The expression displays a typical
hyperbolic dependence on ATPi concentration that saturates at ATP .
4.0 mM.
The rate of the sarcolemmal Ca21 pump studied as a function of ATP
concentration also exhibits a hyperbolic shape with saturation at high ATP
levels (Fig. 2,G andH). As in the case of the AMATPase, and in the normal
physiological range of adenine nucleotide levels, the ﬂux through the sar-
colemmal Ca21 pump will be nearly ATP-independent.
The absolute rates of ATP consumption in the integrated model were
calculated based on the absolute ﬂuxes or currents sustained by the ATP-
consuming processes multiplied by the stoichiometry of such processes,
e.g., 1 ATP is hydrolyzed by SERCA when transporting one Ca21 from the
cytosolic into the sarcoplasmic reticulum compartment. The resulting ﬂuxes
of ATP consumption were compared with available experimental evidence
by Ebus and Stienen (30) and validated by showing that simulated con-
sumption ﬂuxes were in the correct range.
Computational methods
Rate expressions for each individual model component have been analyzed
for their kinetic properties as a module. We usedMatLab 6.5 (TheMathWorks,
Natick, MA) to study each rate expression separately from the assembled
model and to check for the adequacy of the rate law and the parameter set
being used. Once the behavior of each rate function proved satisfactory, the
code of the ECME model, written in C11, was assembled as a system of 50
ordinary differential equations (ODEs) in the development environment of
Microsoft Visual Studio (Microsoft, Redmond, WA). Equations were inte-
grated numerically using CVODE, a stiff ODEs solver in C, developed by
Cohen and Hindmarsh (31), that uses variable-coefﬁcient Adams and BDF
methods (http://citeseer.ist.psu.edu/1230.html).
Before starting to run any speciﬁc protocol, we simulated the behavior of
the system without stimulation to reach a steady state. Subsequently, the
model was run for ;800 s with pacing at 0.25 Hz. The state attained after
800 s is, in fact, a point in a steady trajectory of state variables. In such a
trajectory it may be veriﬁed that most of the EC coupling related variables
(e.g., V, [Ca21]i, and the level of Ca
21 in the dyadic subspace: [Ca21]SS)
change periodically as a result of the periodic stimulus (illustrated in
Supplementary Material, Fig. S1). Since the trajectories described by the
variables are constant, this state will be described as a pseudo-steady state,
which deﬁned the initial condition for all runs in a series of experiments. The
different protocols tested were programmed as a subroutine in the main ﬁle
of the program code. Changes in the pacing frequency were programmed
according to the experimental protocol of Brandes and Bers ((17,32); see
their article, section called Time-Dependent Changes inWorkload), but were
entered manually for the pseudo-steady state studies of the force-frequency
relations. During simulation, the results output is stored as text ﬁles that are
analyzed later with the assistance of Microcal Origin 6.0 (Microcal
Software, Northampton, MA).
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Experimental methods
Muscle preparation and experimental setup
Male LBN-F1 rats weighing 175–250 g (Harlan Sprague Dawley; Indian-
apolis, IN) were anesthetized by intraperitoneal injection of 1.0 ml/kg pen-
tobarbital sodium (360 mg/ml). After intracardiac heparinization, the hearts
were rapidly excised and placed in Krebs-Henseleit buffer containing (in
mM): 120 NaCl, 5 KCl, 2 MgSO4, 1.2 NaH2PO4, 20 NaHCO3, 0.25 Ca
21,
and 10 glucose (pH 7.4). Additionally, 20 mM 2,3-butanedione monoxime
(BDM) was added to the dissection buffer to prevent cutting injury. The
effects of BDM after brief exposure have been found to be reversible (33).
Hearts were cannulated via the ascending aorta and retrogradely perfused
with the same buffer equilibrated with 95% O2–5% CO2. A ﬂat, uniform,
unbranched trabecula from the right ventricle was carefully dissected, leaving
a block of tissue at one end from the right ventricle free wall and a small part
of the valve at the other end to facilitate mounting. The dimensions of the
muscles were measured using a calibration reticle in the ocular of the dis-
section microscope. The muscles have an oval cross-sectional proﬁle with an
average width of 0.29 6 0.05 mm and a thickness of 0.097 6 0.028 mm.
This small muscle dimension assures an adequate supply of oxygen to the whole
tissue volume. The cross-sectional area, calculated assuming an ellipsoid shape,
averaged 0.022 mm2. All experimental protocols conformed to Johns Hopkins
University institutional guidelines regarding the use and care of animals.
Trabeculae were mounted between a basket-shaped extension of the force
transducer and a hooklike extension of a micromanipulator screw with the
aid of a dissection microscope. This attachment and mounting procedure was
chosen because it proved to minimize damage to the muscle preparation (34).
The muscles were stretched until a further increase in length would cause the
resting and developed tensions to increase in parallel, corresponding to a sarco-
mere length (2.2 mm) that is slightly below the maximal developed tension (34).
To monitor the contractile parameters during the experiment, each twitch
was analyzed on-line with a subroutine developed for LabVIEW (Ver. 6.1,
National Instruments, Austin, TX) that acquires and processes the raw data
from the force transducer. The forces developed by the rat trabeculae were
computed in mN.mm2. These were displayed as relative changes in force to
compare them with the simulations, since the model was based on guinea-
pig EC coupling properties, which produces different absolute tensions.
Respiration measurements
We used a ﬁber-optic oxygen sensor (Ocean Optics, Dunedin, FL) to mea-
sure muscle respiration. This probe works as a spectrometer-coupled chemi-
cal sensor for full spectral analysis of dissolved oxygen pressure. The principle
of detection is the ﬂuorescence emission at 600 nm of a ruthenium com-
pound that is quenched by O2. At the tip of the ﬁber optic probe (Ø ¼ 300
mm), the O2-sensitive compound is embedded in a resin. The ﬂuorescence
emitted is a function of the O2 dissolved in the surroundings of the probe.
The respiratory ﬂux was measured with the ﬁber-optic device monitoring
the O2 levels close to the surface of contracting trabeculae (within 200 mm)
upon interruption of the perfusion ﬂow during a 45-s to 1-min interval.
FIGURE 2 ATP/ADP dependence of cytoplasmic and sarcolemmal pumps. (A and B) The dependence of the SERCA ﬂux (Jup) on cytoplasmic ATP. Panel
A shows experimental data redrawn from Sakamoto and Tonomura (21) and panel B shows model simulations using the SERCA rate equation (Eq. 6). The
curves labeled 0, 0.3, 0.6, 1.2, and 2.0 mM illustrate the inhibitory effect of increasing ADP concentration. The parameters were set to: Vmax f ¼ 60 nmol mg1
protein min1; Vmax r¼ 64 nmol mg1 protein min1; [Ca21]i¼ 0.5 mM; and [Ca21]NSR¼ 0.3 mM. All the other parameters are as indicated in Table 7. (C and
D) The dependence of the myoﬁbrillar adenosine triphosphatase (VAM) on cytoplasmic ATP. Panel C shows experimental data redrawn from Karatzaferi et al.
(24) and panel D shows model simulations obtained with Eq. 7 (also Eq. A122). The competitive inhibition by ADP is shown for ADP concentrations of 0.5
and 2.0 mMADP. The plots were produced with a maximal rate of the myoﬁbrillar ATPase, VmaxAM , of 2.88 s
1, and P1¼ 0.2, P2¼ 0.7, and P3¼ 0.1. Otherwise,
the parameters used in the plot are as indicated in Table 11. (E and F) The dependence of the Na1, K1 adenosine triphosphatase activity on ATP. Experimental
data (E, from (21)) and model simulations (F) using the rate expression of Eq. 8. Competitive inhibition by ADP at 0, 0.5, 1.0, and 2.0 mM concentrations is
shown. The parameters used were Vmax ¼ 3.93 mmol mg1 min1, the membrane potential is 80 mV, and the intracellular Na1 is 7.0 mM. The other
parameters are as indicated in Table 3. (G and H) The dependence of the sarcolemmal Ca21 adenosine triphosphatase activity on ATP. Experimental data
(G, from (29)) and model simulations (H) obtained with Eq. 9, which corresponds to a typical Michaelis-Menten proﬁle. The following parameter values were
used in the simulation: Vmax ¼ 2.55 mmol mg1 min1; [Ca21]i ¼ 2 mM; and ADP ¼ 50 mM. The rest of the parameter values are as indicated in Table 6.
Panels A and E are reproduced from Sakamoto and Tonomura (21) by permission of the Japanese Biochemical Society and Oxford University Press. PanelC is from
Karatzaferi et al. (24) used with permission from the American Physiological Society. Panel G is reproduced from Pasa et al. (29) with permission from Elsevier.
1568 Cortassa et al.
Biophysical Journal 91(4) 1564–1589
Under these conditions, we recorded a linear change in the ﬂuorescent sig-
nal whose slope is proportional to the respiratory ﬂux. As expected, the
respiratory rate increases with the frequency of stimulation and the Ca21
levels in the buffer bathing the muscle. The measurements were referred to
the maximal levels of respiration attained under the experimental conditions
described in the presence of the uncoupler FCCP (1 mM). The respiratory
ﬂux was completely inhibited in the presence of NaCN (5 mM). All our
experimental recordings were performed at 22C.
RESULTS
Force-frequency relations
Fundamental cardiac muscle properties were explored by ex-
amining the energetic and inotropic responses to an increase
in stimulation frequency. This force-frequency relation is mus-
cle type- (atrial or ventricular) and species-speciﬁc (35,36).
The force-frequency relation has been studied under pseudo
steady-state and transient conditions (see next section).
Pseudo steady-state studies
The force versus frequency studies under pseudo-steady state
in silico conditions were performed by varying the frequency
of pacing and analyzing the model behavior after;500–1000 s
(8–15 min) of simulation time at each frequency.
Systolic (maximal) and diastolic (minimal) forces were
computed from the behavior during one beat immediately
after 800 s of simulation under each parametric condition.
Developed force was computed as the difference between the
systolic and the diastolic force. Fig. 3 A shows dependence
of developed force as a function of frequency at three dif-
ferent levels of extracellular Ca21, [Ca21]o. In the range of
[Ca21]o studied, force increased linearly with frequency,
attaining a value of 32 mN mm2 at 2.0 Hz in 2.0 mM Ca21.
The slope of the force-frequency relationship increased with
increased [Ca21]o. The increment in developed tension cor-
relates with the increase in the amplitude of the Ca21
transient in the cytosol (see Supplementary Material, Fig. S2).
This ‘‘positive staircase’’ results from enhanced time-averaged
Ca21 entry and SR Ca21 loading and is, in part, indirectly
inﬂuenced by intracellular Na1 concentration, which modu-
lates SR Ca21 load by shifting the balance of Ca21 ﬂuxes
through the actions of the sarcolemmal Na1/Ca21 exchanger.
Simulated force-frequency relations (Fig. 3 A) qualita-
tively resembled those obtained experimentally in the cardiac
rat trabeculae (Fig. 3 B). However, quantitative differences
were found between experimental data and model predic-
tions, especially for values obtained at low Ca21 concentra-
tion. The slope of the force versus frequency relationship at
1.0 mM extracellular Ca21 was much larger in the exper-
iments than in the model (Fig. 3). In the simulations, force
values changed by 30-fold when stimulation frequency
increased from 0.25 to 2.0 Hz, whereas in rat trabeculae,
force increased only approximately threefold in the presence
of 1.0 mM extracellular Ca21 between 0.25 and 2 Hz.
The bioenergetic performance of the system, monitored
through the rate of oxygen consumption (VO2), was also studied
using the same experimental setup for isometric force mea-
surements in rat ventricular trabeculae (see Experimental
Methods). In this way, we could not only directly compare
experimental contractile activity with in silico data but also
measure VO2 as a function of the pacing frequency. The value
VO2 increased with the frequency of stimulation in the model
under pseudo steady-state conditions, depending on [Ca21]o
(Fig. 4 A). At high [Ca21]o, the frequency-VO2 relationship
displays a close to linear dependence, which was also reﬂected
in simulations of the NADH levels (not shown). In the model,
an increase in frequency will increase the levels of cytosolic
Ca21 and ADP, which will be translated into higher mito-
chondrial [Ca21]m and [ADP]m (not shown) to activate two
main mechanisms for activating oxidative phosphorylation.
[Ca21]m will stimulate the TCA cycle dehydrogenases, whereas
[ADP]m will activate respiration through respiratory control.
The close-to-linear increase in respiration with frequency is
likely due to a larger effect of the TCA dehydrogenases stimu-
lation by Ca21 than the corresponding ADP stimulation of
respiration as also suggested by the NADH proﬁle (not shown).
FIGURE 3 Force-frequency relations.
Developed force simulated by the ECME
model (A) and measured in experiments
on rat ventricular trabeculae (B) as a func-
tion of the pacing frequency at various
extracellular Ca21 levels. The simula-
tions were run for 1500 s from the initial
condition indicated in Table 16. The
parameters used are as described in
Tables 1–15 except for the extracellular
Ca21 concentration, which is indicated in
the legend. The developed force was
calculated after the model reached a
pseudo-steady state from the difference
between the maximum and the minimum
forces during a contraction. The experi-
ment data point shown for 1.5 mM Ca21
at 0.25 Hz corresponded to a developed
tension of 45 mN mm2.
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Model simulations were qualitatively in line with the
experimental data obtained in rat ventricular trabeculae (Fig.
4 B). Representing the combined data from Figs. 3 and 4 as
the respiratory rate versus developed tension shows the pro-
portionality between respiration and mechanical work that
has been reported previously in working hearts (37) (see
Supplementary Material, Fig. S3). The quantitative differ-
ences observed in Fig. 4 are, at least in part, due to the fact
that the model has been designed and the parameters ad-
justed for the dynamics of guinea-pig ventricular myocytes,
while the experimental system corresponds to rat ventricular
trabeculae (see Discussion).
Time-dependent behavior of mitochondrial
energetics after changes in workload
We explored the time-dependent behavior of the model with
a protocol in which the stimulus frequency was raised from
0.25 to 2.0 Hz and then returned to 0.25 Hz. This protocol
has been previously used experimentally in a preparation of
ventricular rat trabeculae while mitochondrial energetic and
EC coupling variables were monitored (17,32).
The increase in pacing frequency produces a drop in the
level of NADH (undershoot, phase I in Fig. 5 A) followed by a
recovery phase (phase II in Fig. 5 A) until a new steadyNADH
level is reached.A subsequent decrease in the pacing frequency
causes an overshoot in the NADH concentration (phase III in
Fig. 5 A), which is later followed by a relaxation toward the
baseline NADH level. The ECME simulation of the same
pacingprotocol used byBrandes andBers (17,32) qualitatively
reproduces the proﬁle of NADH and Ca21m recorded experi-
mentally (Fig. 5, A and B). The magnitude of the NADH
decrease during the undershoot is somewhat lower than that
observed experimentally (3% against 10%, respectively).
The ATP and CrP levels of the pool related to EC coupling
during the transient is shown in Fig. 5 C. The decrease in
ATP after the increase in pacing frequency is barely notice-
able, because of the efﬁcient buffering by CrP, whose levels
decrease ;3 mM. This result may be compared with the
changes associated with an increase in heart rate in ferret
hearts, whose phosphorylated energy intermediates were
monitored over time with 31P NMR (38). Our simulations
reproduce the proﬁle in CrP when glycolysis is not operating.
Moreover, the model behavior also simulates the lack of change
in the total ATP observed during stimulation at 2 Hz (38).
Ca21- and ADP-mediated regulatory
mechanisms involved in mitochondrial
energy supply
Once validated, an advantage of the integrated model is that
it may be used to test competing hypotheses reported in the
literature concerning the various mechanisms involved in the
regulation of energy supply and demand in the heart. A sim-
ilar approach was followed in the case of the isolated mi-
tochondrial model (16).
Two basic control mechanisms are incorporated into the
model, so it was essential to determine the independent con-
tributions of each in the transient responses to the perturbation
of workload. First, respiratory control by ATP consumption
leading to increased ADP concentrations in both the cyto-
plasm and the mitochondrial matrix was eliminated by
clamping cytosolic ATP and ADP to a constant levels. Sec-
ond, the Ca21-dependence of the activation of the Krebs
cycle dehydrogenases was adjusted to abolish the upstream
effect of Ca21 to increase NADH production. This was ac-
complished by eliminating the effects of Ca21 on the IDH
and KGDH rates (Eqs. A147 and A149). Both tests were
performed with the same parameter set and frequency range
used in the control simulation shown in Fig. 5 A.
As shown in Fig. 6, when ATPi is clamped, the dynamics
of the simulated mitochondrial NADH signal are completely
altered. Upon an increase in pacing frequency, there is no
undershoot of the NADH signal and the NADH increases
monotonically with a rate similar to that observed during the
recovery phase of the transient in the earlier simulations
FIGURE 4 Respiration associated
with force-frequency relations. O2 con-
sumption simulated by the ECME
model (A) and measured in rat ventric-
ular trabeculae (B) as a function of the
pacing frequency at various extracellu-
lar Ca21 levels. The plots in panel A
were obtained from the same simula-
tions reported in Fig. 3. The experi-
mentally determined rate of respiration,
VO2, is expressed relative to the maxi-
mum observed when the muscle was
exposed to the uncoupler FCCP. Treat-
ment with 5 mM NaCN completely
inhibited the respiratory ﬂux. The sim-
ulated VO2 was averaged after the
model reached a pseudo-steady state.
Under steady-state resting conditions,
VO2 averaged 0.08 mM s
1.
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(phase II, Fig. 5 A). The NADH overshoot (phase III) is also
eliminated when ATPi is clamped (Fig. 6 A).
Removing Ca21-dependent activation of the dehydrogen-
ases (Fig. 6 B) reveals the underlying effect of the stimu-
lation of respiration by ADP. When pacing frequency is
increased, the concentration of NADH drops to lower levels
than in the control (compare phases I, in Figs. 5 A and 6 B)
and does not recover (compare phases II, in Figs. 5 A and
6 B). Upon return to the low pacing frequency, NADH in-
creases monotonically in time (Fig. 6 B).
These results illustrate how the interplay between ADP-
dependent stimulation of respiration and Ca21-mediated
activation of the Krebs cycle dehydrogenases accounts for
the transient kinetics of the NADH response during changes
in workload. Changes in force are rapidly manifested as
changes in the NADH oxidation rate by respiration, leading
to a net decrease, or increase, in the NADH signal when
workload is increased, or decreased, respectively. The some-
what slower response time of mitochondrial Ca21 dynamics
and activation of NADH production by the Ca21 stimulation
of the TCA cycle dehydrogenases contributes to the recovery
of the NADH signal during the undershoot and to the NADH
overshoot when workload decreases. Brieﬂy, the NADH
initial undershoot is linked to the sudden increase in respi-
ratory rate not counterbalanced by an increased NADH pro-
duction by mitochondrial dehydrogenases. Later, during the
recovery phase, NADH production is activated by Ca21
stimulation of the TCA cycle dehydrogenases. These remain
activated even after the sudden drop in respiration that occurs
when the pacing rate is decreased. This transient imbalance
explains the overshoot in NADH that slowly relaxes to a
lower NADH level when the mitochondrial Ca21 levels
decrease and dehydrogenases activation ceases.
The simultaneous regulatory effects of Ca21 andADPwere
further explored in the simulations shown in Fig. 7. When the
rate of ATP hydrolysis by themyoﬁbrillar ATPasewas halved
there was a decrease in the amplitude of the NADH transients
(undershoot and overshoot) in accordwith the smaller changes
in ATP and ADP (Fig. 7 A: compare the solid trace at lower
maximal ATPase rate, with the shaded control proﬁle).
In contrast, if the maximal rate of the mitochondrial Ca21
uniporter is decreased to 1/10th of the control value, the
NADH proﬁle resembles that obtained in the absence of
stimulation of Krebs cycle dehydrogenases by Ca21 (com-
pare Figs. 7 C and 6 B). The lack of a recovery phase (evident
in the solid trace of Fig. 7 C) is attributable to the extremely
low levels of [Ca21]m attained during this protocol (Fig. 7D).
FIGURE 5 Mitochondrial energetics in response to changes in workload.
Model simulations are shown for a change in the myocyte pacing frequency
from 0.25Hz (0–100 s) to 2.0 Hz (100–300 s) and back to 0.25Hz (300–500 s).
The parameters and initial conditions used in the simulations are as indicated
in Tables 1–16. The NADH time course (A) and mitochondrial matrix Ca21
concentrations (B) are plotted. Regions I, II, and III indicate the different
phases in the temporal evolution of the NADH signal. Panel C shows the
proﬁle of [ATP]i and [CrP]i obtained in the same simulation.
FIGURE 6 Contribution of Ca21 activation of mitochondrial dehydro-
genases and respiratory control by ADP to mitochondrial NADH dynamics.
(A) The proﬁle of NADH in simulations run with the pacing protocol
indicated in Fig. 5, with myoplasmic ATP (both ATPi and ATPic) clamped.
(B) The NADH proﬁle when the factor accounting for the stimulation by
Ca21 of IDH and KGDH is eliminated from the corresponding equations
(see Eqs. A145 and A148).
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Effects of stimulation frequency on transient
bioenergetic and contractile behavior
To subject the ECME model to a more comprehensive and
stringent test, we monitored the dynamics of mitochondrial
energetics (VO2, ADPm, NADH) and contractile work
(force), as well as the two main effectors, Ca21m and
ADPm, while the stimulatory frequency was varied over a
wide range. The pacing frequency was increased from a
baseline of 0.25 Hz to a higher frequency, e.g., 0.5, 1.0, 1.5,
or 2.0 Hz, and returned to 0.25 Hz as indicated in the diagram
at the top of Fig. 8. This in silico experiment emulates the
experimental protocol reported by Brandes and Bers ((32)
Fig. 8 B) and tests how changes in the average force and
Ca21 transport work contribute to the different phases of the
mitochondrial NADH transient. ECMEmodel simulations of
the average force and the transient kinetics of the NADH
proﬁle qualitatively reproduce the experimental results (Fig.
8 A). The contractile activity drives changes in the adenine
nucleotide pool and the respiratory ﬂux (Fig. 8 C), in close
correlation with the average force (Fig. 8 A). Fig. 8 D shows
how the responses of ADPm and Ca
21
m can account for the
larger undershoot/overshoot and recovery phases of the
NADH signal as the frequency increases.
DISCUSSION
A mathematical model was developed in which the elec-
trical, Ca21 handling and contractile properties of the cardiac
myocyte were integrated with mitochondrial bioenergetics.
The ECME model is able to reproduce the pseudo-steady
state and, importantly, the dynamic proﬁle of changes in es-
sential physiological variables such as ADP, NADH, and
Ca21 in cardiac myocytes subjected to changes in stimula-
tion frequency and/or external Ca21. Interactions between
sarcolemmal and mitochondrial ion transport mechanisms,
ATP consumption, and oxidative phosphorylation were
sufﬁciently robust to simulate the matching of energy supply
and demand over a range of workloads.
Excitation-contraction coupling/mitochondrial
energetics model description
The excitation-contraction coupling/mitochondrial energet-
ics (ECME) model is the ﬁrst to integrate detailed biophys-
ical descriptions of the activity of cardiac ion channels,
sarcolemmal and mitochondrial ion transport pathways,
excitation-contraction coupling, and myoﬁlament activation
with a model of mitochondrial oxidative phosphorylation.
This allowed us to explore the interrelationship between the
principal energy-consuming processes of the cell (i.e., con-
traction and ion transport) and the energy-generating system.
Signaling between the cytosolic processes and mitochondrial
bioenergetics was accomplished by 1), coupling the pools
of high-energy phosphate intermediates in the cytoplasmic
and mitochondrial compartments; and 2), linking Ca21
levels in the two compartments via the mitochondrial Ca21
uniporter and Na1/Ca21 exchanger. The key to accurately
simulating the dynamic and steady-state responses of
FIGURE 7 Effect of changing the my-
oﬁbrillar ATPase and mitochondrial
Ca21 uniporter on the ECME model
energetic behavior after changes in work-
load. (A) The behavior of NADH in
simulations with the pacing protocol and
parametric conditions as described in the
legend of Fig. 5, except that the maximal
rate of ATP hydrolysis by the AM-
ATPase was decreased to one-half (solid
trace;VmaxAM ¼ 3:6 103 mM ms1) of the
control value (shaded trace). (B) The
proﬁle of average ATPi for changes in
workload under control conditions
(shaded trace) or with decreased myoﬁ-
brillar ATPase activity (solid trace). (C)
The NADH proﬁle in model simulations
with the same pacing protocol and pa-
rameters as described in the legend of
Fig. 5, but with the maximal rate of the
mitochondrial Ca21 uniporter decreased
to 1/10th (solid trace; Vunimax ¼ 2:75 103
mM ms1) of the control value (shaded
trace). (D) The proﬁle of [Ca21]m accu-
mulation for the low uniporter condition
described in panel C (solid trace) as
compared to the control (shaded trace).
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bioenergetics to changes in workload lies in the balance be-
tween stimulation of the respiratory chain by enhanced ATP
hydrolysis and stimulation of the Krebs cycle dehydrogen-
ases. The differences in the relative response times of these
two processes can account for the transient overshoot and
undershoot behavior of mitochondrial NADH. Experimental
evidence supporting a direct link in the response time of
Krebs cycle dehydrogenases activation by mitochondrial
Ca21 and the recovery kinetics of NADH was provided by
Brandes and Bers (17).
As in our previous model of the isolated mitochondrion
(16), we have sought to reproduce the dynamic response to
an abrupt change in workload as the most stringent test of the
integrated model. In this regard, there have been few studies
in which mitochondrial responses have been recorded in
parallel with force measurements, so we have relied heavily
on the data of Brandes and Bers (17), who recorded NADH
transients, mitochondrial Ca21 accumulation, and force in a
unbranched rat cardiac trabecula preparation. Whether this
preparation accurately reproduces the time course of change
of the same parameters in an in vivo setting will require
comparable recordings of all the variables of interest in the
intact heart.
Nevertheless, the model results demonstrate that for
changes in workload induced by increasing or decreasing
stimulation frequency, the NADH dynamics of the muscle
can be described by the combination of ADP-dependent and
Ca21-dependent regulatory mechanisms. Small changes in
ATPi, and consequently in the levels of ADP in the cyto-
plasmic and mitochondrial compartments, mediate rapid
changes in the mitochondrial NADH/NAD1 redox state.
When ATPi was clamped, the rapid decrease in NADH upon
an increase in work was eliminated, as was the overshoot
when work was decreased. In this condition, NADH
FIGURE 8 Inotropic and bioenergetic transient behavior of the ECME model as a function of the pacing frequency. (A and B) The NADH and average
developed force proﬁles during transients in workload at various frequencies in simulations (A) and experiments (B) (from (32)). The simulation protocol
consists of abrupt changes in pacing frequency from 0.25 Hz to 0.5, 1.0, 1.5, and 2.0 Hz, as indicated in the bar diagram at the top of panel A. (C) The average
oxygen consumption rate (in mM s1) with the NADH proﬁle shown for reference. (D) The time course of the two effectors of the bioenergetic machinery
(average ADPm and Ca
21
m ) that are involved in the energetic response to a change in workload. Parameters and initial conditions are the same as those used in
Figs. 3–5 Panel B was reproduced from Brandes and Bers (32) by copyright permission of the Biophysical Society.
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increased and decreased monotonically as workload was
varied, primarily reﬂecting the effects of Ca21 on the rate of
NADH production by the Krebs cycle. In the model, the
Ca21-sensitive dehydrogenases IDH and KGDH exert the
most control over mitochondrial NADH levels when ATP is
clamped (16).
When the Ca21 sensitivity of the Krebs cycle dehydro-
genases was eliminated in the model, the effects of mito-
chondrial ADP on NADH oxidation were revealed clearly.
An acute increase in average force is rapidly translated via
the adenine nucleotide pool to an increase in respiration and,
conversely, a decrease in work quickly results in a decrease
in the rate of NADH oxidation by the respiratory chain. This
raises the important question of how to model the high-
energy phosphate transfer system between the sites of ATP
consumption in the cytoplasm and ATP production by the
mitochondria. This is a subject of ongoing debate (7) that
must take into consideration the local spatial organization of
the cardiomyocyte and the kinetics of the buffering reactions
mediated by creatine kinase (and, ideally, other buffers like
adenylate kinase as well). From ﬁrst-principles, at high work
load, mitochondrial ATP production has to match the
approximately eightfold increase in the rate of ATP hydro-
lysis by the actomyosin ATPase. Hence, ADP inﬂux across
the mitochondrial inner membrane must increase in parallel.
In cardiac muscle, the creatine kinase system can act as both
an ATP buffer and a high-energy phosphate shuttle (39).
This presents a problem in a model that does not formally
incorporate spatial aspects with respect to incorporating the
ability of the CK reaction to buffer the bulk cytosolic ATP
concentration, while still being able to describe rapid ADP
and Pi delivery to the mitochondrial adenine nucleotide and
phosphate transporters, which are thought to be in a complex
with the mitochondrial ATP synthase (40). As a compro-
mise, we have included two nucleotide pools in the model, a
bulk cytosolic pool that is largely buffered by the CK
reaction and a pool with minimal buffering associated with
the excitation-contraction coupling processes. The latter pool
allows the mitochondria to rapidly and directly sense
changes in energetic demand via mitochondrial ADP con-
centration. This representation should not be viewed as a
literal description of compartmentation in the physical
system, but as a construct that allowed us to simulate rapid
phosphoryl (i.e., high energy phospho-group) transfer to and
from the mitochondria without creating a computationally
intractable spatial model of the cell (requiring partial dif-
ferential equations).
Comparison of model and experimental results
The incorporation of both the ADP- and Ca21-dependent
regulatory mechanisms was required to adequately describe
the experimental data of Brandes and Bers (32) with regard
to the different effects of changes in work associated with
contractile activity and the work associated with changes in
Ca21 handling. Contractile activity can be varied in the
absence of a change in average cytosolic Ca21 by changing
resting sarcomere length, while Ca21 homeostasis can be
varied by changing stimulation frequency, external Ca21, or
inotropic intervention (e.g., b-adrenergic receptor stimula-
tion). In response to an increased pacing rate, mitochondrial
NADH transiently decreases (phase I) and then recovers
(phase II; Fig. 5 A) (32). The phase II recovery of NADH
depends on the average cytosolic (and consequently mito-
chondrial) Ca21, and the net redox state attained after
equilibration to the new workload is strongly affected by the
sarcomere length. As the sarcomere length approaches the
optimum of the Frank-Starling curve (i.e., Lmax), average
force for any given Ca21 is increased and the total energetic
demand is increased, thus leading to a net oxidation of the
NADH/NAD1 redox pool. Our simulations show that ADPm,
which reﬂects changes in cytosolic ADP, accounts for the
initial rapid decline of NADH at the onset of high frequency
stimulation (Figs. 6 B and 7 A, and Fig. 8, A and D). The
rapid decrease in ADPm as the workload is lowered also
underlies the transient overshoot of NADH during the proto-
col. At this point, NADH production, which was accelerated
by Ca21 stimulation of the dehydrogenases, remains acti-
vated, while NADH oxidation decreases more rapidly. Again,
the balance between the relaxation times of the demand-led
and Krebs cycle processes determines the overall proﬁle.
The effect of increasing the pacing rate in ferret hearts
results in unchanged ATP levels and an initial decrease of
CrP followed by a recovery to steady-state levels (if gly-
colysis is operating) (38). In the absence of glycolytic ﬂux,
the recovery phase of CrP is not observed and upon return to
the low pacing frequency CrP level increases to reach the
original steady-state levels (38). The model simulations
reproduce the condition in the absence of glycolysis (Fig.
5 C) since according to the model, only mitochondrial ATP
synthesis can replenish CrP. The change in Pi could not be
directly computed because the operation of the adenine
nucleotide translocator is carrying phosphoryl groups into
the cytoplasm whose ﬂux is counterbalanced by the phos-
phate carrier (not accounted for by the model). However, the
main determinant of Pi dynamics in the cytosol is CrP, thus
the Pi should mirror the CrP concentration proﬁle when
subjected to changes in pacing frequency (not shown).
Another agreement between our simulations and the
experimental results concern the cytosolic levels of metab-
olites: [ATP], [NADH], [CrP], and [Ca21], which are very
close to the physiological values observed in ventricular
myocytes of various species. As a matter of fact, NADH is
highly reduced in the mitochondrial matrix (;75%) (17).
Since the total concentration of mitochondrial pyrimidine
nucleotides is 10 mM in our model, an 80% reduction will
correspond to 8 mM NADH (Fig. 5 A), which resembles the
value reported (17). ATP was reported to be in the order of
7.5 mM; CrP is ;21 mM at low pacing frequency, and can
decrease up to 15mM (38). Ca21 resting level is;100–200 nM
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whereas the systolic concentration can peak from 400 nM to
1 mM (41).
A sensitivity analysis (data not shown) performed at 0.25,
1.0, and 2 Hz under the same parametric conditions as those
used in the experiments shown in Figs. 3–5 revealed that the
steps to which respiratory or ATP synthesis ﬂuxes were most
sensitive were localized downstream of NADH. This is in
accordance with our earlier metabolic control analysis carried
out for the isolated mitochondrial model (16). In the case of
the integrated model, the processes that inﬂuence the rate of
ATP hydrolysis are now explicitly described in a detailed
physiological context, thus leading to important interdepen-
dencies between the steps that strongly inﬂuence E-C cou-
pling and energetics.
It should be noted that Balaban and co-workers (1) have
failed to observe NADH transients in intact hearts of the type
reported by Brandes and Bers, leading to the notion that
energy supply is rapidly increased to meet energetic demand
through fast parallel activation of the respiratory chain and
Krebs cycle dehydrogenases by a cytoplasmic messenger.
Potential candidates for the active messenger include Ca21
(12) or Pi (13), while ADP was thought to play a diminished
role in the process. In isolated mitochondria, respiration was
shown to respond rapidly (within hundreds of milliseconds)
to changes in both Ca21 and ADP (12). However, van Beek
and co-workers (42) stated that the transient changes in
energy ﬂuxes and intermediates do not necessarily occur si-
multaneously and are altered upon inhibition of creatine
kinase and/or glycolytic ﬂux (43). The transient time was
found to be much shorter for adenine nucleotides than for
respiration, arguing against simultaneous parallel activation
of energy production and consumption by a single, common
effector (42). Further investigation into the transient dynam-
ics of respiration, Ca21, force, NADH, and ATP turnover in
response to changes in cardiac workload will be required to
resolve these issues. Our results indicate that Ca21 and ADP,
affecting mitochondrial energetics with different response
times, are sufﬁcient to reproduce available experimental data.
Mixed regulation of mitochondrial energetics would poten-
tially confer more ﬂexibility to the heart in responding to
different physiological challenges, for example, as could
occur when changes in workload are elicited by variations in
ADP with or without associated changes in the average
cytosolic Ca21 (32,44).
Directions for further model development
In taking on the challenge of incorporating most of the
fundamental functional properties of the cardiac myocyte,
the present integrated model is able to qualitatively repro-
duce the pseudo-steady state and transient responses of mito-
chondrial oxidative phosphorylation to changes in cardiac
work. Semiquantitative agreement with the force-respiration
relationship obtained in isolated cardiac trabeculae subjected
to various pacing frequencies and external Ca21 concentra-
tions was also achieved. Quantitative differences between
our simulations and available experimental data can, in part,
be explained by differences in the E-C coupling properties of
the rat (which we choose for experiments due to the exten-
sive validation of this preparation in our laboratory and
others) and the Guinea-pig (which serves as a well estab-
lished model representative of the E-C coupling properties of
larger mammals) (41). The relative contributions of SERCA
and the Na1/Ca21 exchanger to the reuptake of cytoplasmic
Ca21 after the peak are different in rats and guinea-pigs. As
a consequence, the fraction of Ca21 that is recycled is much
larger in rats than in guinea-pigs. The rat trabeculae experi-
ments were carried out at 22C whereas the model param-
eters were adjusted for currents and ﬂuxes operating at 37C.
This is another source of variation and further experimen-
tation with different species and temperature will be required
to determine their contribution to quantitative discrepancies
with the model.
The feasibility of ADP and Ca21 as important mediators
of energy supply and demand matching has been demon-
strated in the present model, but this work does not preclude
the possibility that other mechanisms/mediators might be
involved. For example, compelling evidence exists that
various steps in the electron transport chain may be regulated
by allosteric mechanisms (45), which would be replicated in
our model by changing the concentration of respiratory
carriers (rres) in response to changes in work. Since the rate
of the mitochondrial ATP synthase is governed by the pro-
tonmotive force and the availability of ADP and Pi, inde-
pendently of the rate of respiration, we have observed in
some simulations that ATP synthesis outpaces the increase in
respiration, resulting an increase in the P/O ratio at high work
(P/O ratio refers to the quotient of the ATP synthesis rate
over the respiratory rate and represents a measure of the
efﬁciency of oxidative phosphorylation). This changing P/O
ratio differs from experimental results obtained in isolated rat
hearts (46), perhaps suggesting an avenue for further re-
ﬁnement and validation of the model.
Cytosolic Ca21 handling in the E-C coupling module has
been previously validated by simulating the short-term interval
force relations of cardiac muscle (15,47). The experimentally
observed behavior of restitution and post-extrasystolic po-
tentiation (48) are also appropriately reproduced in the in-
tegrated model (see Supplementary Material, Fig. S4).
According to the model, Na1 levels determine, to a certain
extent, the level of Ca21 and the rate of Ca21 removal
through the Na1,Ca21 exchanger activity. This is reﬂected
by the accumulation of Na1 as frequency increases (see
Supplementary Material, Fig. S2). Nevertheless, we have not
accounted yet for important processes inﬂuencing cytosolic
Na1 levels such as the Na1,H1 exchanger, which may
render a more accurate picture of this cation.
A more controversial issue is to what extent the mito-
chondria will inﬂuence the cytosolic Ca21 transient and how
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rapidly Ca21 is taken up by the mitochondria (49). Indeed,
we (50) and others (49,51) have obtained evidence that Ca21
may be taken up rapidly by the mitochondria during the
Ca21 transient. This again raises the question of the spatial
organization of the components of the model, as mentioned
above when considering high-energy phosphate transfer
rates. This is another area that will likely require further
reﬁnement of the model and experimentation. As formulated
in this study, the mitochondria responded to the bulk
cytoplasmic Ca21 concentration and did not substantially
alter the Ca21-induced Ca21 release process of the junctional
space.
Comparison with other mathematical models
There have been few previous attempts to develop compu-
tational models linking electrophysiology, ion homeostasis,
Ca21 handling, ATP consumption, and mitochondrial ener-
getics. Magnus and Keizer (52) developed a model that
incorporated plasmalemmal ion channels, Ca21 handling,
and ATP production by glycolysis and mitochondria to
simulate the bursting behavior of pancreatic b-cells. Ele-
ments of that model were used as components of our pre-
vious isolated cardiac mitochondrial model (16), with
extensive modiﬁcations including the addition of NADH
as a state variable, dependent on the activity of the Krebs
cycle. In the present model, both Ca21 and ADP are now
variables that depend on the sum total of physiological
processes associated with E-C coupling and mitochondrial
function. The only remaining important ﬁxed inﬂux is the
supply of Acetyl CoA to the Krebs cycle, which could be
reﬁned in the future by incorporating established models of
glycolysis and b-oxidation of fatty acids. This could account
for potential limitations of higher-order substrate supply,
which could be relevant to the simulation of pathological
conditions.
Another recent model based on a sound electrophysiolog-
ical formulation focused on the interactions between the
mitochondrial and cytoplasm space with Ca21 as the sole
signaling molecule (53). Presumably owing to the lack of
signiﬁcant respiratory control in the mitochondrial compo-
nent of this model (54), the interrelationship between a
change in E-C coupling and bioenergetics is not well
described.
Saks and collaborators (7,9,55,56) have also modeled the
energetic processes linked to muscle contraction, but they
did not take into account the electrophysiology of the cell.
Their model was more oriented to processes occurring in the
cytoplasm and mitochondrial intermembrane space, includ-
ing creatine kinase and adenylate kinase and was intended to
address the some of the spatial aspects of phosphoryl transfer
that we have discussed above. Force generation in this model
was an adjustable function used to calculate its contribution
to energy consumption rather than as a biophysical descrip-
tion of contraction.
Concluding remarks
We have developed an integrated model of the electro-
physiology, E-C coupling properties, and mitochondrial bio-
energetic responses of the cardiac myocyte. The model
reproduces the pseudo steady-state force-respiration relation-
ship and is also capable of describing the transient energetic
responses to abrupt changes in workload. The ECME model
can be used to explore the important interactions between the
electrical, contractile metabolic functions of the heart, which
will lead to an improved quantitative understanding of
cardiac physiology under normal or pathological conditions.
APPENDIX
Ionic currents
Fast Na1 current (INa)
INa ¼ GNa m3h j ðV  ENaÞ; (A1)
ENa ¼ RT
F
ln
½Na1 o
½Na1 i
 
; (A2)
dmNa
dt
¼ amð1 mNaÞ  bmmNa; (A3)
dhNa
dt
¼ ahð1 hNaÞ  bhhNa; (A4)
djNa
dt
¼ ajð1 jNaÞ  bj jNa; (A5)
am ¼ 0:32 V1 47:13
1 e0:1ðV1 47:13Þ; (A6)
bm ¼ 0:08 eV=11: (A7)
For V $ 40 mV
ah ¼ 0:0; (A8)
aj ¼ 0:0; (A9)
bh ¼ 0:13 11 e
V110:66
11:1ð Þ 	 	1; (A10)
bj ¼ 0:3
e
2:5353107V
11 e0:1ðV132Þ
: (A11)
For V ,40 mV
ah ¼ 0:135 e
801V
6:8 ; (A12)
aj ¼ ð127; 140 e0:2444V  3:4743105 e0:04391VÞ
3
V1 37:78
11 e0:311ðV179:23Þ
; (A13)
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bh ¼ 3:56 e0:079V1 3:13 105 e0:35V; (A14)
bj ¼ 0:1212
e
0:01052V
11 e0:1378ðV140:14Þ
: (A15)
See Table 1.
Time-dependent delayed rectiﬁer K1 current (IK)
IK ¼ GKX1X2ðV  EKÞ; (A16)
EK ¼ RT
F
ln
½K1 
o
1PNa;K½Na1 o
½K1 i1PNa;K½Na1 i
 
; (A17)
GK ¼ 0:282
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½K1 
o
5:4
s
; (A18)
X1 ¼ ð11 eðV40Þ=40Þ1; (A19)
dX
dt
¼ axð1 XÞ  bxX; (A20)
ax ¼ 7:19 105 V1 30
1 e0:148ðV130Þ; (A21)
bx ¼ 1:31 104
V1 30
11 e0:0687ðV130Þ: (A22)
Time-independent K1 current (IK1)
IK1 ¼ GK1K1NðV  EK1Þ; (A23)
EK1 ¼
RT
F
ln
½K1 
o
½K1 
i
 
; (A24)
GK1 ¼ 0:75
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½K1 o
5:4
s
; (A25)
K1N ¼ aK1
aK1 1bK1
; (A26)
aK1 ¼
1:02
11 e0:2385ðVEK159:215Þ
; (A27)
bK1 ¼
0:4912 e
0:08032ðVEK115:476Þ1 e0:06175ðVEK1594:31Þ
11 e0:5143ðVEK11 4:753Þ
: (A28)
Plateau K1 current (IKp)
IKP ¼ GKP KPðV  EKPÞ; (A29)
EKP ¼ EK1 ; (A30)
Kp ¼ ð11 eð7:488VÞ=5:98Þ1: (A31)
Na1/Ca21 exchanger current (INaCa)
INaCa ¼ kNaCa 1
K
3
m;Na1 ½Na1 3o
1
Km;Ca1 ½Ca21 o
3 11 ksat e
ðh1ÞVFRT
 	1
3 eh
VF
RT½Na13i ½Ca21o  eðh1Þ
VF
RT½Na1 3o½Ca21i
n o
:
(A32)
See Table 2.
Na1, K1 pump current (INaK)
INaK ¼ INaK fNaK f ATPNaK 11
Km;Nai
½Na1 i
 1:5 !1 ½K1 o
½K1 o1Km;Ko
;
(A33)
fNaK ¼ 110:1245e0:1
VF
RT10:0365e
VF
RT
e
½Na1 o=67:31
7
 ! !1
;
(A34)
f
ATP
NaK ¼ 11
K
1;ATP
NaK
½ATPi
11
½ADPi
K
i;ADP
NaK
  1
: (A35)
See Table 3.
TABLE 1 General parameters
Symbol Value Units Description Eq. Refs.
F 96.5 C mmol1 Faraday constant.
T 310 K Absolute temperature.
R 8.314 J mol1 K1 Universal gas constant.
Cm 1.0 mF cm
2 Membrane capacitance. A79 (14)
Acap 1.534 10
4 cm2 Capacitative cell
surface area.
A88 (14)
Vmyo 25.84 pL Cytosolic volume. A88 (14)
Vmito 15.89 pL Mitochondrial volume. A92 (57)
VNSR 1.4 pL NSR volume. A91 (15)
VJSR 0.16 pL JSR volume. A89 (15)
VSS 0.495 10
3 pL SS volume. A89 (15)
[K1]o 5.4 mM Extracellular K
1
concentration.
A17 (14)
[Na1]o 140.0 mM Extracellular Na
1
concentration.
A2 (14)
[Ca21]o 2.0 mM Extracellular Ca
21
concentration.
A32 (14)
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Nonspeciﬁc Ca21 activated current (Ins(Ca))
InsðCaÞ ¼ InsðNaÞ1 InsðKÞ; (A36)
InsðNaÞ ¼ InsðNaÞ 11 Km;nsðCaÞ½Ca21 i
 3 !1
; (A37)
InsðNaÞ ¼ PnsðNaÞ VF
2
RT
0:75ð½Na1 ieVF=RT  ½Na1 oÞ
e
VF=RT  1 ; (A38)
InsðKÞ ¼ InsðKÞ 11 Km;nsðCaÞ½Ca21 i
 3 !1
; (A39)
InsðKÞ ¼ PnsðKÞ VF
2
RT
0:75ð½K1ieVF=RT  ½K1oÞ
eVF=RT  1 : (A40)
Background Ca21 current (ICa,b)
ICa;b ¼ GCa;bðV  ECa;NÞ; (A41)
ECa;N ¼ RT
2F
ln
½Ca21 o
½Ca21 
i
 
: (A42)
Background Na1 current (INa,b)
INa:b ¼ GNa;bðV  ENa;NÞ; (A43)
ENa;N ¼ ENa: (A44)
See Tables 4 and 5.
Sarcolemmal Ca21 pump current (IpCa)
IpCa ¼ IpCa max FATPpCa
½Ca12
i
K
pCa
m 1 ½Ca12i
; (A45)
F
ATP
pCa ¼ 11
K
ATP
m1 pCa
½ATP
i
11
½ADP
i
K
ADP
i pCa
 ! !1
1 11
K
ATP
m2 pCa
½ATP
i
 !1
:
(A46)
See Table 6.
SERCA pump (Jup)
Jup ¼ Vmaxf fb  Vmaxr rb
11 fb1 rb
f
SERCA
ATP ; (A47)
fb ¼ ½Ca
21i
Kfb
 Nfb
; (A48)
rb ¼ ½Ca
21NSR
Krb
 Nrb
; (A49)
f
SERCA
ATP ¼
K
ATP
m;up
½ATPi
11
½ADPi
Ki;up
 
1 11
½ADPi
Ki;up9
  !1
:
(A50)
See Table 7.
TABLE 2 Membrane current parameters
Symbol Value Units Description Eq. Refs.
GNa 12.8 mS mF
1 Maximal Na
channel conductance.
A1 (14)
GKP 8.28 3 10
3 mS mF1 Maximal plateau K
channel conductance.
A29 (14)
PNa,K 0.01833 Na
1 permeability of
K1 channel.
A17 (14)
kNaCa 9000 mA mF
1 Scaling factor of
Na1/Ca1 exchange.
A32 (15)
km,Na 87.5 mM Na half-saturation
constant NCX.
A32 (14)
km,Ca 1.38 mM Na half-saturation
constant NCX.
A32 (14)
ksat 0.1 Na
1/Ca21 exchange
saturation factor
at negative potentials.
A32 (14)
h 0.35 Controls voltage
dependence of NCX.
A32 (14)
TABLE 3 Na1/K1 pump parameters
Symbol Value Units Description Eq. Refs.
INaK 3.147 mA mF
1 Maximum Na1/K1
pump current.
A33 *
Km,Nai 10 mM Na half-saturation
for Na1/K1 pump.
A33 (14)
Km,Ko 1.5 mM K half-saturation
for Na1/K1 pump.
A33 (14)
K1;ATPNaK 8.0 3 10
3 mM ATP half-saturation
constant for
Na1/K1 pump.
A35 (21)
Ki;ADPNaK 0.1 mM ADP inhibition constant
for Na1/K1 pump.
A35 (21)
*Adjusted based on the value of Na1 concentration to match physiological
levels (58,59).
TABLE 4 Nonspeciﬁc channel current parameters
Symbol Value Units Description Eq. Refs.
PnsðNaÞ 1.75 3 10
7 cm s1 Nonspeciﬁc channel
current Na permeability.
A38 (26)
Km,ns(Ca) 1.2 3 10
3 mM Ca21 half-saturation c
onstant for nonspeciﬁc
current.
A37 (14)
PnsðKÞ 0 cm s
1 Nonspeciﬁc channel
current K permeability.
A40 (15)
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L-type Ca21 current (ICa)
a ¼ 0:4 eðV12Þ=10; (A51)
b ¼ 0:05 eðV12Þ=13; (A52)
a9 ¼ aa; (A53)
b9 ¼ b
b
; (A54)
g ¼ 0:1875 ½Ca21ss; (A55)
dCo
dt
¼ bC11vCCaO  ð4a1 gÞCo; (A56)
dC1
dt
¼ 4aCo1 2bC21v
b
CCa1  ðb1 3a1 agÞC1; (A57)
dC2
dt
¼ 3aC11 3bC31 v
b
2 CCa2  ð2b1 2a1 a2gÞC2;
(A58)
dC3
dt
¼ 2aC21 4bC41 v
b
3 CCa3  ð3b1a1 a3gÞC3;
(A59)
dC4
dt
¼ aC31 gO1 v
b4
CCa4  ð4b1 f 1 a4gÞC4; (A60)
dO
dt
¼ f C4  gO; (A61)
dCCa0
dt
¼ b9CCa11 gC0  ð4a91vÞCCa0; (A62)
dCCa1
dt
¼ 4a9CCaO1 2b9CCa21 agC1  b91 3a91v
b
 	
CCa1;
(A63)
dCCa2
dt
¼ 3a9CCa113b9CCa31a2gC2 2b912a91 v
b
2
 
CCa2;
(A64)
dCCa3
dt
¼ 2a9CCa214b9CCa41a3gC3 3b91a91 v
b
3
 
CCa3;
(A65)
dCCa4
dt
¼a9CCa31g9OCa1a4gC4 4b91 f 91v
b
4
 
CCa4;
(A66)
dOCa
dt
¼ f 9CCa4 g9OCa; (A67)
ICamax ¼ 4PCa
VF
2
RT
0:001e
2VF=RT0:341 ½Ca21 o
e
2V=RT 1 ; (A68)
ICa ¼ 6 ICamax y½O; (A69)
ICa;K ¼PK9y½O1OCaVF
2
RT
½K1
i
eVF=RT½K1
o
e
VF=RT1 ; (A70)
PK9¼ PK
11
ICamax
ICahalf
; (A71)
TABLE 5 Background Ca21 current parameters
Symbol Value Units Description Eq. Refs.
GCa;b 3.217 3 10
3 mS mF1 Maximum background
current Ca21
conductance.
A41 *
GNa;b 5.45 3 10
4 mS mF1 Maximum background
current Na1
conductance.
A43 *
*Adjusted from Jafri et al. (14) and Rice et al. (15), based on physiological
levels of Ca21 and Na1 in cardiomyocytes (41,58).
TABLE 6 Sarcolemmal Ca21 current parameters
Symbol Value Units Description Eq. Refs.
IpCa_max 0.575 mA mF
1 Maximum sarcolemmal
Ca21 pump current.
A45 (15)
KpCam 5 3 10
4 mM Ca21 half-saturation
constant for
sarcolemmal Ca21
pump.
A45 (14)
KATPm1 pCa 0.012 mM First ATP half-saturation
constant for
sarcolemmal Ca21
pump.
A46 (60)
KATPm2 pCa 0.23 mM Second ATP half-saturation
constant for
sarcolemmal Ca21 pump.
A46 (60)
KADPi pCa 1.0 mM ADP inhibition constant
for sarcolemmal
Ca21 pump.
A46 (29)
TABLE 7 Sarcoplasmic reticulum Ca21 ATPase parameters
Symbol Value Units Description Eq. Refs.
Vmax,f 2.989 3 10
4 ms1 SERCA forward rate
parameter.
A47 (14)
Vmax,r 3.179 3 10
4 ms1 SERCA reverse rate
parameter.
A47 (14)
Kfb 2.4 3 10
4 mM Forward Ca21
half-saturation
constant of SERCA.
A48 (15)
Krb 1.64269 mM Reverse Ca
21
half-saturation
constant of SERCA.
A49 (15)
Nfb 1.4 Forward cooperativity
constant of SERCA.
A48 (15)
Nrb 1.0 Reverse cooperativity
constant of SERCA.
A49 (15)
KATPm;up 0.01 mM ATP half-saturation
constant for SERCA.
A50 (21)
Ki;up 0.14 mM ADP ﬁrst inhibition
constant for SERCA.
A50 (21)
Ki;up9 5.1 mM ADP second inhibition
constant for SERCA.
A50 (21)
Integrated Energetics-EC Coupling Model 1579
Biophysical Journal 91(4) 1564–1589
dy
dt
¼ yN y
ty
; (A72)
yN ¼ 1
11eðV155Þ=7:5
1
0:5
11eðV121Þ=6
; (A73)
ty ¼ 201 600
11eðV130Þ=9:5
: (A74)
See Table 8.
Ca21 release channel current (Jrel)
dPC1
dt
¼k1a ½Ca21 nssPC11ka PO1; (A75)
dPO1
dt
¼ k1a ½Ca21 nssPC1 ka PO1  k1b ½Ca21 mssPO1
1kb PO2  k1c PO11kc PC2; (A76)
dPO2
dt
¼ k1b ½Ca21 mssPO1  kb PO2; (A77)
dPC2
dt
¼ k1c PO1  kc PC2; (A78)
Jrel ¼ v1ðPO11PO2Þð½Ca21 JSR ½Ca21 SSÞ: (A79)
See Table 9.
Sarcolemmal membrane potential
dV
dt
¼ 1
Cm
INa1 ICa1 ICa;K1 IK1 IK11 IKp1 INaCa

1 INaK1 IinsðCaÞ1 IpCa1 ICa;b1 INa;bÞ: (A80)
Ca21 buffering and diffusive
transport between compartments
Jtrpn ¼ d½HTRPNCa
dt
1
d½LTRPNCa
dt
; (A81)
Jtr ¼ ½Ca
21NSR ½Ca21JSR
ttr
; (A82)
Jxfer ¼ ½Ca
21
SS
½Ca21
i
txfer
; (A83)
bi ¼ 11
K
CMDN
m ½CMDNtot
ðKCMDNm 1 ½Ca21 iÞ2
 !1
; (A84)
bSS ¼ 11
K
CMDN
m ½CMDNtot
ðKCMDNm 1 ½Ca21 SSÞ2
 !1
; (A85)
bJSR ¼ 11
K
CSQN
m ½CSQNtot
ðKCSQNm 1 ½Ca21 JSRÞ2
 !1
; (A86)
d½HTRPNCa
dt
¼ k1htrpn ½Ca21i ð½HTRPNtot ½HTRPNCaÞ
 khtrpn ½HTRPNCa;
(A87)
d½LTRPNCa
dt
¼ k1ltrpn ½Ca21i ð½LTRPNtot½LTRPNCaÞ
 kltrpn 1
2
3
ForceNorm
 
½LTRPNCa:
(A88)
See Table 10.
Ionic concentrations in various compartments
d½Ca21 i
dt
¼ bi Jxfer  Jup  Jtrpn ðICa;b2 INaCa1 IpCaÞ
Acap
2VmyoF

1ðVNaCa VuniÞVmito
Vmyo

; (A89)
TABLE 8 L-type Ca21 current parameters
Symbol Value Units Description Eq. Refs.
A 2.0 Mode transition
parameter.
A53 (14)
B 2.0 Mode transition
parameter.
A54 (14)
v 0.01 ms1 Mode transition
parameter.
A56 (14)
f 0.3 ms1 Transition rate into
open state.
A61 (14)
g 2.0 ms1 Transition rate out of
open state.
A61 (14)
f’ 0.0 ms1 Transition rate into
open state, mode Ca.
A67 (14)
g9 0.0 ms1 Transition rate out
open state, mode Ca.
A67 (14)
PCa 1.24 3 10
3 cm s1 L-type Ca21 channel
permeability to Ca21.
A68 (15)
PK 1.11 3 10
11 cm s1 L-type Ca21 channel
permeability to K1.
A71 (15)
ICahalf 0.4583 mA mF1 ICa level that reduces
PK by half.
A71 (15)
TABLE 9 Ca21 release channel current parameters
Symbol Value Units Description Eq. Refs.
v1 3.6 ms
1 RyR ﬂux
channel constant.
A79 (15)
n 4 Cooperativity
parameter.
A75 (14)
m 3 Cooperativity
parameter.
A76 (14)
k1a 1.215 3 10
10 mM4 ms1 RyR rate constant. A75 (14)
ka 0.576 ms
1 RyR rate constant. A75 (61)
k1b 4.05 3 10
6 mM3 ms1 RyR rate constant. A76 (14)
kb 1.93 ms
1 RyR rate constant. A76 (14)
k1c 0.1 ms
1 RyR rate constant. A76 (61)
kc 8.0 3 10
4 ms1 RyR rate constant. A76 (14)
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d½Ca21 ss
dt
¼ bss Jrel
VJSR
Vss
 JxferVmyo
Vss
ðICaÞ Acap
2VssF
 
; (A90)
d½Ca21JSR
dt
¼ b
JSR
½Jtr  Jrel; (A91)
d½Ca21NSR
dt
¼ Jup Vmyo
VNSR
 Jtr VJSR
VNSR
; (A92)
d½Ca21
m
dt
¼ dðVuniVNaCaÞ; (A93)
d½Na1i
dt
¼ðINa1 INa;b1 Ins;Na13 INaCa13 INaKÞ Acap
VmyoF
;
(A94)
d½K1
i
dt
¼ ðIK1 IK11 IKp1 Ins;K1 ICa;K2 INaKÞ
Acap
VmyoF
:
(A95)
Force generation model (15)
d½Po
dt
¼ðktroppn 1 f01Þ ½Po1ktropnp ½N01g01ðSLÞ ½P1; (A96)
d½P1
dt
¼ðktroppn 1 f121g01ðSLÞÞ ½P11ktropnp ½N1
1 f01 ½P01g12ðSLÞ ½P2; (A97)
TABLE 10 Ca21 transport and buffering parameters
Symbol Value Units Description Eq. Refs.
ttr 0.5747 ms Time constant for
transfer from
subspace to
myoplasm.
A82 (15)
txfer 9.09 ms Time constant for
transfer from
NSR to JSR.
A83 (15)
KCMDNm 2.38 3 10
3 mM Ca21 half saturation
constant for
calmodulin.
A84 (15)
KCSQNm 0.8 mM Ca
21 half saturation
constant for
calsequestrin.
A85 (15)
k1htrpn 100 mM
1 ms1 Ca21 on-rate for
troponin
high-afﬁnity sites.
A86 (15)
khtrpn 3.3 10
4 ms1 Ca21 off-rate for
troponin
high-afﬁnity sites.
A87 (15)
k1ltrpn 100 mM
1 ms1 Ca21 on-rate
for troponin
low-afﬁnity sites.
A88 *
kltrpn 4 3 10
2 ms1 Ca21 off-rate
for troponin
low-afﬁnity sites.
A88 (14)
[HTRPN]tot 0.14 mM Total troponin
high-afﬁnity sites.
A87 (14)
[LTRPN]tot 0.07 mM Total troponin
low-afﬁnity sites.
A88 (14)
[CMDN]tot 5.0 3 10
2 mM Total myoplasmic
calmodulin
concentration.
A84 (14)
[CSQN]tot 15 mM Total NSR calsequestrin
concentration.
A85 (15)
*Adjusted from the value reported in Rice et al. (15) to reproduce the values
of the developed force by ventricular guinea-pig muscles, as described in
Ruf et al. (62).
TABLE 11 Force generation parameters
Symbol Value Units Description Eq. Refs.
ktroppn 0.04 ms
1 Transition rate from
tropomyosin permissive
to nonpermissive.
A96 (15)
SL 2.15 mm Sarcomere length. A111 (15)
fXB 0.05 ms
1 Transition rate from
weak to strong
crossbridge.
A102 *
gminXB 0.1 ms
1 Minimum transition rate
from strong to
weak crossbridge.
A105 *
z 0.1 N mm2 Conversion factor
normalizing to
physiological force.
A120 (15)
VmaxAM 7.2 3 10
3 mM ms1 Maximal rate of ATP
hydrolysis by myoﬁbrils
(AM ATPase).
A122 y
KATPM;AM 0.03 mM ATP half-saturation
constant of AM ATPase.
A122 (24)
Ki;AM 0.26 mM ADP inhibition
constant of AM ATPase.
A122 (24)
*Adjusted from the value reported in Rice et al. (15) to reproduce the values
of the developed force by ventricular guinea-pig muscles, as described in
Ruf et al. (62).
yEstimated from Ebus and Stienen (30).
TABLE 12 Cytoplasmic energy handling parameters
Symbol Value Units Description Eq. Refs.
CT 25 mM Total concentration of
creatine metabolites
(both compartments).
(63,64)
kcytoCK 1.4 3 10
4 ms1 Forward rate constant
of cytoplasmic CK.
A140 *
kmitoCK 1.33 3 10
6 ms1 Forward rate constant
of mitochondrial CK.
A141 *
kCrtr 2.0 3 10
3 ms1 Transfer rate constant
of CrP.
A142 *
KEQ 0.0095 Equilibrium constant
of CK.
A140 (63)y
VcytoATPase 1.0 10
5 mM ms1 Constitutive cytosolic
ATP consumption rate.
A125 z
*The forward rate constants of the CK reaction were adjusted to reproduce
the range of values from Clark et al. (67).
yThe equilibrium constant was averaged from that reported by Selivanov et
al. (62) and the one by Saupe et al. (66) including the proton concentration
[H1] inside the equilibrium constant.
zCalculated according to the 25% of the resting energy being used for
macromolecular turnover as reported by Ingwall and Weiss (65).
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TABLE 13 Tricarboxylic acid cycle parameters
Symbol Value Units Description Eq. Refs.
[AcCoA] 1.0 mM Acetyl CoA concentration. A143 (16)
kCScat 0.05 ms
1 Catalytic constant of CS. A143 *
ECST 0.4 mM Concentration of CS. A143 (16)
KAcCoAM 1.26 3 10
2 mM Michaelis constant for AcCoA. A143 (16)
KOAAM 6.4 3 10
4 mM Michaelis constant for OAA. A143 (16)
CKint 1.0 mM Sum of TCA cycle intermediates’ concentration. A138 (16)
kACOf 1.25 3 10
2 ms1 Forward rate constant of ACO. A144 (16)
KACOE 2.22 Equilibrium constant of ACO. A144 (16)
KaADP 0.62 mM Activation constant by ADP. A145
y
KaCa 0.0005 mM Activation constant for Ca
21. A145 y
Ki;NADH 0.19 mM Inhibition constant by NADH. A146 (16)
kIDHcat 0.03 ms
1 Rate constant of IDH. A147 *
EIDHT 0.109 mM Concentration of IDH. A147 (16)
[H1] 2.5 3 105 mM Matrix proton concentration. A147 (16)
kh,1 8.1 3 10
5 mM Ionization constant of IDH. A147 (16)
kh,2 5.98 3 10
5 mM Ionization constant of IDH. A147 (16)
KISOCM 1.52 mM Michaelis constant for isocitrate. A147 (16)
Ni 2.0 Cooperativity for isocitrate. A147 (16)
KNADM 0.923 mM Michaelis constant for NAD
1. A147 (16)
KMg
21
D 0.0308 mM Activation constant for Mg
21. A148 (16)
KCa
21
D 1.27 3 10
3 mM Activation constant for Ca21. A148 (16)
EKGDHT 0.5 mM Concentration of KGDH. A149 (16)
kKDGHcat 0.05 ms
1 Rate constant of KGDH. A149 *
KaKGM 1.94 mM Michaelis constant for aKG. A149 (16)
KNADM 38.7 mM Michaelis constant for NAD. A149 (16)
naKG 1.2 Hill coefﬁcient of KGDH for aKG. A149 (16)
Mg21 0.4 mM Mg21 concentration in mitochondria. A148 (16)
kSLf 5.0 3 10
4 mM1 ms1 Forward rate constant of SL. A150 *
KSLE 3.115 Equilibrium constant of the SL reaction. A150 (16)
[CoA] 0.02 mM Coenzyme A concentration. A150 (16)
kSDHcat 3.0 3 10
3 ms1 Rate constant of SDH. A151 *
ESDHT 0.5 mM SDH enzyme concentration. A151 (16)
KSucM 0.03 mM Michaelis constant for succinate. A151 (16)
KFUMi 1.3 mM Inhibition constant by fumarate. A151 (16)
KOAAi;sdh 0.15 mM Inhibition constant by oxalacetate. A151 (16)
kFHf 3.32 3 10
3 ms1 Forward rate constant for FH. A152 *
KFHE 1.0 Equilibrium constant of FH. A152 (16)
kh1 1.13 3 10
5 mM Ionization constant of MDH. A153 (16)
kh2 26.7 mM Ionization constant of MDH. A153 (16)
kh3 6.68 3 10
9 mM Ionization constant of MDH. A154 (16)
kh4 5.62 3 10
6 mM Ionization constant of MDH. A154 (16)
koffset 3.99 3 10
2 pH-independent term in the pH activation factor of MDH. A153 (16)
kMDHcat 0.111 ms
1 Rate constant of MDH. A155 *
EMDHT 0.154 mM Total MDH enzyme concentration. A155 (16)
KMALM 1.493 mM Michaelis constant for malate. A155 (16)
KOAAi 3.1 3 10
3 mM Inhibition constant for oxalacetate. A155 (16)
KNADM 0.2244 mM Michaelis constant for NAD
1. A155 (16)
[GLU] 10.0 mM Glutamate concentration. A156 (16)
kAATf 6.44 3 10
4 ms1 Forward rate constant of AAT. A156 (16)
KAATE 6.6 Equilibrium constant of AAT. A156 (16)
kASP 1.5 3 10
6 ms1 Rate constant of aspartate consumption. A156 *
*The kinetic constants of all the TCA cycle enzyme steps have been multiplied by a factor of 1.5–4 with respect to those indicated in Cortassa et al. (16) to
match the ﬂuxes of the TCA cycle (68) in the integrated model that faces additional restrictions than those of the isolated mitochondrial model.
yThe values of the isocitrate dehydrogenase activation constants by ADP and Ca21 have been modiﬁed to reproduce appropriately the kinetics reported by
Rutter and Denton (68).
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d½P2
dt
¼ðf231g12ðSLÞÞ ½P21 f12 ½P11g23ðSLÞ ½P3; (A98)
d½P3
dt
¼g23ðSLÞ ½P31 f23 ½P2; (A99)
d½N1
dt
¼ ktroppn ½P11ðktropnp 1g019 ðSLÞÞ ½N1; (A100)
½N0 ¼ 1ð½N11 ½P01 ½P11 ½P21 ½P3Þ; (A101)
f01 ¼ 33 fXB; (A102)
f12 ¼ 103 fXB; (A103)
f23 ¼ 73 fXB; (A104)
g01 ¼ 13gminXB ; (A105)
g12 ¼ 23gminXB ; (A106)
g23 ¼ 33gminXB ; (A107)
g01ðSLÞ ¼ 13f3gminXB ; (A108)
g12ðSLÞ ¼ 23f3gminXB ; (A109)
g23ðSLÞ ¼ 33f3gminXB ; (A110)
f¼ 11 2:3SLð2:31:7Þ1:6; (A111)
k
trop
np ¼ ktroppn
½LTRPNCa
K
trop
1=2 ½LTRPNtot
" #Ntrop
; (A112)
K
trop
1=2 ¼ 11
K
trop
Ca
1:710
30:8103ðSL1:7Þ
0:6
0
B@
1
CA
1
; (A113)
N
trop ¼ 3:53SL2:0; (A114)
KtropCa ¼
kltrpn
k
1
ltrpn
; (A115)
TABLE 14 Oxidative phosphorylation parameters
Symbol Value Units Description Eq. Refs.
ra 6.394 3 10
13 ms1 Sum of products of rate constants. A157 (16)
rb 1.762 3 10
16 ms1 Sum of products of rate constants. A158 (16)
rc1 2.656 3 10
22 ms1 Sum of products of rate constants. A157 (16)
rc2 8.632 3 10
30 ms1 Sum of products of rate constants. A157 (16)
r1 2.077 3 10
18 Sum of products of rate constants. A157 (16)
r2 1.728 3 10
9 Sum of products of rate constants. A157 (16)
r3 1.059 3 10
26 Sum of products of rate constants. A157 (16)
rres 3.0 3 103 mM Concentration of electron carriers
(respiratory complexes I-III-IV).
A157 (16)
Kres 1.35 3 10
18 Equilibrium constant of respiration. A159 (16)
rres(F) 3.75 3 104 mM Concentration of electron carriers
(respiratory complexes II-III-IV).
A161 *
DCB 50 mV Phase boundary potential. A157 (16)
G 0.85 Correction factor for voltage. A157 (16)
Kres(F) 5.765 3 10
13 Equilibrium constant of FADH2 oxidation. A162 (16)
[FADH2] 1.24 mM Concentration of FADH2 (reduced). A162 (16)
[FAD] 0.01 mM Concentration of FAD (oxidized). A162 (16)
pa 1.656 3 10
8 ms1 Sum of products of rate constants. A163 (16)
pb 3.373 3 10
10 ms1 Sum of products of rate constants. A164 (16)
pc1 9.651 3 10
17 ms1 Sum of products of rate constants. A163 (16)
pc2 4.585 3 10
17 ms1 Sum of products of rate constants. A163 (16)
p1 1.346 3 10
8 Sum of products of rate constants. A163 (16)
p2 7.739 3 10
7 Sum of products of rate constants. A163 (16)
p3 6.65 3 10
15 Sum of products of rate constants. A163 (16)
rF1 1.5 mM Concentration of F1F0-ATPase. A163 (16)
KF1 1.71 3 10
6 Equilibrium constant of ATP hydrolysis. A165 (16)
Pi 2.0 mM Inorganic phosphate concentration. A165 y
CA 1.5 mM Total sum of mito adenine nucleotides. A129
y
VmaxANT 0.025 mM ms
1 Maximal rate of the ANT. A139 (16)
hANT 0.5 Fraction of DCm. A139 (16)
gH 1.0 3 10
8 mM ms1 mV1 Ionic conductance of the inner membrane. A166 (16)
DpH 0.6 pH units pH gradient across the inner membrane. A167 (16)
CPN 10.0 mM Total sum of mito pyridine nucleotides. A160 (16)
Cmito 1.812 3 10
3 mM mV1 Inner membrane capacitance. A123 (16)
*The respiratory complex II carriers concentration was adjusted with respect to the value in Cortassa et al. (16) to match the reported range of oxygen
consumption rates (0.04–0.5 mM s1 ¼ 5–60 mMol O2/min/mg) (1).
yThe total nucleotide level and inorganic phosphate were corrected with respect to previous publication (16) to follow reported experimental evidence (1,69).
Integrated Energetics-EC Coupling Model 1583
Biophysical Journal 91(4) 1564–1589
+PATHS ¼ g01 g12 g23 1 f01 g12 g23 1 f01 f12 g23 1 f01 f12 f23;
(A116)
P1max ¼
f01 g12 g23
+PATHS
; (A117)
P2max ¼
f01 f12 g23
+PATHS
; (A118)
P3max ¼
f01 f12 f23
+PATHS
; (A119)
Force ¼ z P11N112P213P3
P1max12P2max13P3max
; (A120)
ForceNorm ¼ P11N11P21P3
P1max1P2max1P3max
; (A121)
VAM ¼ VmaxAM
f01 ½P01 f12 ½P11 f23 ½P2
f011 f121 f23
 
3 11
K
ATP
M;AM
½ATP
i
11
½ADPi
Ki;AM
  !1
: (A122)
See Table 11.
Mitochondrial membrane potential (DWm)
dDCm
dt
¼ VHe1VHeðFÞ VHu VANT VHLeak VNaCa 2Vuni
Cmito
:
(A123)
Energy metabolites
d½ATP
i
dt
¼ VANTVmito
Vmyo
 VmitoCK VAM 
1
2
Jup
ðIpCa1 INaKÞ Acap
VmyoF
; (A124)
d½ATPic
dt
¼ VcytoCK VcytoATPase; (A125)
d½CrPi
dt
¼ VmitoCK VCrPtr ; (A126)
d½CrPic
dt
¼ VCrPtr 1VcytoCK ; (A127)
d½ADP
m
dt
¼ VANT VATPaseVSL; (A128)
½ATPm ¼ CA½ADPm; (A129)
d½NADH
dt
¼ VO21VIDH1VKGDH1VMDH; (A130)
d½ISOC
dt
¼ VACO VIDH; (A131)
d½aKG
dt
¼ VIDH VKGDH1VAAT; (A132)
d½SCoA
dt
¼ VKGDH VSL; (A133)
d½Suc
dt
¼ VSL VSDH; (A134)
d½FUM
dt
¼ VSDHVFH; (A135)
d½MAL
dt
¼ VFHVMDH; (A136)
d½OAA
dt
¼ VMDH VCS VAAT; (A137)
½CIT ¼ CKint  ½ISOC1 ½aKG1 ½SCoA1 ½Sucð
1 ½FUM1 ½MAL1 ½OAAÞ: (A138)
TABLE 15 Mitochondrial Ca21 handling parameters
Symbol Value Units Description Eq. Refs.
Vunimax 0.0275 mM ms
1 Vmax uniporter
Ca21 transport.
A168 *
DC 91 mV Offset membrane
potential.
A168 (16)
Kact 3.8 3 10
4 mM Activation constant. A168 (16)
Ktrans 0.019 mM Kd for translocated
Ca21.
A168 (16)
L 110.0 Keq for conformational
transitions in
uniporter.
A168 (16)
na 2.8 Uniporter activation
cooperativity.
A168 (16)
VNaCamax 1.0 3 10
4 mM ms1 Vmax of Na
1/Ca21
antiporter.
A169 (16)
b 0.5 DCm dependence
of Na1/Ca21
antiporter.
A169 (16)
KNa 9.4 mM Antiporter Na
1
constant.
A169 (16)
KCa 3.75 3 10
4 mM Antiporter Ca21
constant.
A169 (16)
n 3 Na1/Ca21 antiporter
cooperativity.
A169 (16)
d 3.0 104 Fraction of
free [Ca21]m.
A93 (16)
*The maximal rate of the Ca21 uniporter had to be adjusted to meet the
transport ﬂuxes experimentally determined (70,71) in the new integrated
model structure in which the Ca21 levels in the cytoplasm are no longer
steady as they were in the isolated mitochondrial model (16).
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Energy metabolism reaction rates
Cytosolic reaction rates
V
cyto
CK ¼ kcytoCK ½ATPic ½Cric
½ADPic ½CrPic
KEQ
 
; (A140)
V
mito
CK ¼ kmitoCK ½ATPi ½Cri
½ADP
i
½CrP
i
KEQ
 
; (A141)
V
CrP
tr ¼ kCrtr ð½CrPi½CrPicÞ: (A142)
See Table 12.
Tricarboxylic acid cycle reaction rates
VCS ¼ kCScat ECST 11
KAcCoAM
½AcCoA1
KOAAM
½OAA

1
K
AcCoA
M
½AcCoA1
K
OAA
M
½OAA
1
; (A143)
VACO ¼ kACOf ½CIT
½ISOC
K
ACO
E
 
; (A144)
f
IDH
a ¼ 11
½ADP
m
KaADP
 
11
½Ca21 
m
KaCa
  1
; (A145)
f
IDH
i ¼ 11
½NADH
Ki;NADH
 
; (A146)
VIDH ¼ kIDHcat EIDHT 11
½H1
kh;1
1
kh;2
½H1 
 
1 f IDHi
K
NAD
M
½NAD
 
1 f IDHa
K
ISOC
M
½ISOC
 ni
1 f IDHa f
IDH
i
K
ISOC
M
½ISOC
 ni
K
NAD
M
½NAD
 #1
;
(A147)
f
KGDH
a ¼ 11
½Mg21 
K
Mg
21
D
 !
11
½Ca21 m
K
Ca
21
D
 !" #1
; (A148)
VKGDH ¼ k
KGDH
cat E
KGDH
T
11 f KGDHa
K
aKG
M
½aKG
 naKG
1 f KGDHa
K
NAD
M
½NAD
; (A149)
VSL ¼ kSLf ½SCoA ½ADPm 
½Suc½ATPm½CoA
KSLE
 
; (A150)
VSDH ¼ k
SDH
cat E
SDH
T
11
K
Suc
M
½Suc
 
11
½OAA
K
OAA
i;sdh
 !
11
½FUM
K
FUM
i
 ; (A151)
VFH ¼ kFHf ½FUM
½MAL
K
FH
E
 
; (A152)
fh;a ¼ 11 ½H
1
kh1
1
½H12
kh1 kh2
 1
1koffset; (A153)
fh;i ¼ 11 kh3½H11
kh3 kh4
½H12
 2
; (A154)
VAAT ¼ kAATf ½OAA½GLU
kASPK
AAT
E
ðkASPKAATE 1 ½aKGkAATf Þ
:
(A156)
See Table 13.
VANT ¼ VmaxANT
0:75 1 0:25 ½ATPi3 0:45 ½ADPm
0:17 ½ADPi3 0:025 ½ATPm
 
e
 FRTDCm
 	
11
0:25 ½ATPi
0:225 ½ADPi
e
hANTFDCm
RT
 
Þ 11 0:45 ½ADPm
0:025 ½ATPm
 
;
 (A139)
VMDH ¼ k
MDH
cat E
MDH
T fh;a fh;i
11
KMALM
½MAL 11
½OAA
K
OAA
i
 
1
KNADM
½NAD1
KMALM
½MAL 11
½OAA
K
OAA
i
 
KNADM
½NAD
; (A155)
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Oxidative phosphorylation reaction rates
VHe ¼
6r
res
ra e
Ares F
RTð Þ  ðra1rbÞe
g6FDmH
RT
  
11r1 e
FAres
RTð Þ 	e 6FDCBRT 1 r21r3 e FAresRTð Þ 	e g6FDmHRT ;
(A158)
Ares ¼RT
F
ln Kres
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½NADH
½NAD1 
s !
; (A159)
½NAD1 ¼CPN½NADH; (A160)
AresðFÞ ¼ RT
F
ln KresðFÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½FADH2
½FAD
s !
; (A162)
VHu ¼
3rF1
10
2
pa 11e
FAF1
RTð Þ 	ðpa1pbÞe 3FDmHRT 
11p1 e
FAF1
RTð Þ 	e 3FDCBRT 1 p21p3 e FAF1RTð Þ 	e 3FDmHRT ;
(A164)
AF1 ¼RT
F
ln KF1
½ATP
m
½ADPmPi
 
; (A165)
VHleak ¼ gHDmH; (A166)
DmH ¼2:303
RT
F
DpH1DCm: (A167)
See Table 14.
Mitochondrial Ca21 handling rates
Vuni ¼
V
uni
max
½Ca21 
i
Ktrans
11
½Ca21 
i
Ktrans
 3
2FðDCm DCoÞ
RT
11
½Ca21 i
Ktrans
 4
1
L
11 ½Ca
21 i
Kact
 	na
0
@
1
A 1 e 2FðDCmDCoÞRT  
;
(A168)
VNaCa ¼VNaCamax
e
bFðDCmDC+Þ
RT
 
e
ln
½Ca21 m
½Ca21 i
 	
11
KNa
½Na1i 
 n
11
KCa
½Ca21 m
 : (A169)
See Tables 15 and 16.
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VO2 ¼ 0:5 rres
ra1 rc1 e
6FDCB
RT
  
e
Ares F
RTð Þ  ra e
g 6 FDmH
RT
 
1 rc2 e
Ares F
RTð Þ e
g 6 FDmH
RT
 
11 r1 e
FAres
RTð Þ 	e 6 FDCBRT 1 r21 r3 e FAresRTð Þ 	 e g 6 FDmHRT  ; (A157)
VHeðFÞ ¼ 4 rresðFÞ
ra e
AresðFÞ F
RT
 
 ðra1 rbÞ e
g 6FDmH
RT
  
11 r1 e
FAresðFÞ
RT
  
e
6 FDCB
RT
 
1 r21 r3 e
FAresðFÞ
RT
  
e
g 6 FDmH
RT
 ; (A161)
VATPase ¼ rF1
10
2
pa1 pc1 e
3 FDCB
RT
  
e
AF1 F
RTð Þ  pa e
3 FDmH
RT
 
1 pc2 e
AF1 F
RTð Þ e
3 FDmH
RT
  
11 p1 e
FAF1
RTð Þ 	e 3 FDCBRT 1 p21 p3 e FAF1RTð Þ 	 e 3 FDmHRT  ; (A163)
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(mitochondrial).
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